• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

26/07/2025 11:33

Alembic Pharmaceutic - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2025, titled ""Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg"".